Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M1 Kliniken AGMKLNF 93 Return-on-Tangible-Asset is 20.01% as of Dec. 2025, which is 53% above its 10-year median of 13.06. GuruFocus rates MKLNF with a GF Score™ of 93/100 and a GF Value™ of $10.20. The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, M1 Kliniken AG ranks better than 98.31% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. M1 Kliniken AG's annualizedNet Income for the quarter that ended in Dec. 2025 was $24.6 Mil. M1 Kliniken AG's average total tangible assets for the quarter that ended in Dec. 2025 was $123.0 Mil. Therefore, M1 Kliniken AG's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 20.01%.
The historical rank and industry rank for M1 Kliniken AG's Return-on-Tangible-Asset or its related term are showing as below:
MKLNF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 3.15 Med: 13.06 Max: 22.19
Current: 21.26
During the past 12 years, M1 Kliniken AG's highest Return-on-Tangible-Asset was 22.19%. The lowest was 3.15%. And the median was 13.06%.
MKLNF's Return-on-Tangible-Asset is ranked better than 98.31% of 118
companies
in the Medical Distribution industry
Industry Median: 2.34
vs MKLNF: 21.26
M1 Kliniken AG (OTCPK:MKLNF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
M1 Kliniken AG Return-on-Tangible-Asset Related Terms
M1 Kliniken AG Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for M1 Kliniken AG's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MKLNF vs MCK, CAH, COR: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, M1 Kliniken AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 20.01% mean?
M1 Kliniken AG (MKLNF) has a Return-on-Tangible-Asset of 20.01% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on M1 Kliniken AG and its competitors. This is 53% above median its historical median of 13.06. Over the past decade, M1 Kliniken AG's Return-on-Tangible-Asset has ranged from 3.15 to 22.19. According to the industry distribution chart, M1 Kliniken AG ranks #2 out of 118 companies in the Medical Distribution industry, placing it in the top 1.7%.
Is M1 Kliniken AG's Return-on-Tangible-Asset too high?
M1 Kliniken AG's current Return-on-Tangible-Asset of 20.01% is 53% above median its 10-year median of 13.06. Over the past 10 years, this metric has ranged from a low of 3.15 to a high of 22.19. The Medical Distribution industry median Return-on-Tangible-Asset is 2.34. M1 Kliniken AG's value of 20.01% is 755.1% above this industry median. Based on the distribution chart, M1 Kliniken AG ranks #2 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, M1 Kliniken AG has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's Return-on-Tangible-Asset compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #2 out of 118 companies for Return-on-Tangible-Asset. This places M1 Kliniken AG in the top 2% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.34. M1 Kliniken AG's value of 20.01% is 755.1% above this benchmark. Historically, M1 Kliniken AG's own Return-on-Tangible-Asset has ranged from 3.15 to 22.19 over the past decade. While the company's 10-year median is 13.06 vs. the industry median of 2.34, M1 Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.34, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current Return-on-Tangible-Asset of 20.01% is 755.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current Return-on-Tangible-Asset is 20.01%, which is 53% above median its own 10-year median of 13.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current Return-on-Tangible-Asset of 20.01%. The stock's GF Value™ is $10.20, compared to a current price of $11.73 — trading 15% above its estimated fair value. The current Return-on-Tangible-Asset is 20.01%, which is 53% above median its 10-year median of 13.06 and 755.1% above the Medical Distribution industry median of 2.34. M1 Kliniken AG's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current Return-on-Tangible-Asset is 20.01% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (MKLNF) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of $11.73 is trading 15% above its estimated GF Value™ of $10.20.
Key valuation signals for MKLNF:
Return-on-Tangible-Asset: 20.01% (53% above median its 10-year median of 13.06)
GF Value™: $10.20 vs. price of $11.73 (15% above fair value)
Industry Position: 755.1% above the Medical Distribution median (#2 of 118)
No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
93GF Score
Get the complete analysis for MKLNF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKLNF has been successfully added to your 
